Brief: Insulet’s radiant trial demonstrates glycemic improvements with Omnipod® 5 automated insulin delivery system
19/03/2025 20:56
March 19 (Reuters) - Insulet Corp PODD.O: INSULET’S RADIANT TRIAL DEMONSTRATES MEANINGFUL GLYCEMIC IMPROVEMENTS WITH THE OMNIPOD® 5 AUTOMATED INSULIN DELIVERY SYSTEM FOLLOWING DIRECT TRANSITION FROM MULTIPLE DAILY INJECTIONS INSULET CORP - NO LIFE-THREATENING ACUTE EVENTS IN RADIANT STUDY Source text: ID:nBw3vdBWRa Further company coverage: PODD.O ((Reuters.Briefs@thomsonreuters.com;))